Health and Healthcare

Celldex Therapeutics : CLDX

All Celldex Therapeutics Articles

48 Articles

Trey Thoelcke | Apr 3, 2014 at 8:30 AM EDT

Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations

New drug innovations are affecting the way that physicians treat such debilitating and deadly diseases as cancer. In a new…

Jon C. Ogg | Mar 10, 2014 at 10:00 AM EDT

Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old

Five years ago, many investors had thrown in the towel. The S&P 500 hit an ominous intraday low of 666…

Trey Thoelcke | Mar 7, 2014 at 9:00 AM EST

Biotech Stocks to Buy After the Pullback

The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the…

Trey Thoelcke | Jan 15, 2014 at 8:40 AM EST

Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014

The new year is well under way and the major firms on Wall Street are all presenting their best stock…

Jon C. Ogg | Jan 7, 2014 at 8:25 AM EST

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers.…

Jon C. Ogg | Jan 10, 2013 at 9:02 AM EST

Five Top Stock Picks Under $15 From Cantor Fitzgerald’s 2013 Conviction Buy List (AHT, CLDX, RFMD, UNIS, VHS)

For the very first time in their long and storied history, Cantor Fitzgerald has come out with a list outlining…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 14, 2012 at 7:59 AM EDT

NASDAQ Changes Up Biotech Index Members & Weightings

Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and…

Jon C. Ogg | May 10, 2012 at 12:02 PM EDT

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors. The king…

Douglas A. McIntyre | May 18, 2011 at 8:57 AM EDT

Top Active Trader Alert Stocks (CLDX, DELL, SODA, SPLS)

Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves…

Douglas A. McIntyre | Nov 22, 2010 at 8:47 AM EST

Top Active Trader Alert Stocks (AFFY, CLDX, CRUS, GMCR, NFLX, NOVL)

Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves…

Jon C. Ogg | Oct 5, 2010 at 8:34 AM EDT

Top Active Trader Alert Stocks (CLDX, GYMB, GERN, WFR, MXL, SIRI, TLB)

Active traders and day traders have many stocks to choose from this morning. We are tracking moves in Celldex Therapeutics,…

Jon C. Ogg | Sep 3, 2010 at 8:27 AM EDT

Top Active Trader Alerts (APC, BRCD, CLDX, FNSR, HRB, MAT, TTWO, ULTA)

Many stocks are on the move this Friday morning. Active traders and day traders are likely to be watching the…

Jon C. Ogg | Jun 7, 2010 at 1:22 PM EDT

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical…

Jon C. Ogg | May 20, 2010 at 7:05 PM EDT

Top After-Hours Movers (BRCD, CLDX, DELL, FL, HOTT, MRVL, NDSN, CRM, RRGB)

We have many movers in the after-hours session. Stocks on the move are Brocade Communications Systems, Inc. (NASDAQ: BRCD), Celldex…

1 2 3 4

Celldex Therapeutics : CLDX

All Celldex Therapeutics Articles

Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations

Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old

Biotech Stocks to Buy After the Pullback

Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

Five Top Stock Picks Under $15 From Cantor Fitzgerald’s 2013 Conviction Buy List (AHT, CLDX, RFMD, UNIS, VHS)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

NASDAQ Changes Up Biotech Index Members & Weightings

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Top Active Trader Alert Stocks (CLDX, DELL, SODA, SPLS)

Top Active Trader Alert Stocks (AFFY, CLDX, CRUS, GMCR, NFLX, NOVL)

Top Active Trader Alert Stocks (CLDX, GYMB, GERN, WFR, MXL, SIRI, TLB)

Top Active Trader Alerts (APC, BRCD, CLDX, FNSR, HRB, MAT, TTWO, ULTA)

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Top After-Hours Movers (BRCD, CLDX, DELL, FL, HOTT, MRVL, NDSN, CRM, RRGB)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Celldex Therapeutics : CLDX

All Celldex Therapeutics Articles

Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations

Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old

Biotech Stocks to Buy After the Pullback

Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

Five Top Stock Picks Under $15 From Cantor Fitzgerald’s 2013 Conviction Buy List (AHT, CLDX, RFMD, UNIS, VHS)

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

NASDAQ Changes Up Biotech Index Members & Weightings

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Top Active Trader Alert Stocks (CLDX, DELL, SODA, SPLS)

Top Active Trader Alert Stocks (AFFY, CLDX, CRUS, GMCR, NFLX, NOVL)

Top Active Trader Alert Stocks (CLDX, GYMB, GERN, WFR, MXL, SIRI, TLB)

Top Active Trader Alerts (APC, BRCD, CLDX, FNSR, HRB, MAT, TTWO, ULTA)

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Top After-Hours Movers (BRCD, CLDX, DELL, FL, HOTT, MRVL, NDSN, CRM, RRGB)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It